Search for: "H. LUNDBECK A/S"
Results 41 - 55
of 55
Sort by Relevance
|
Sort by Date
6 May 2009, 3:29 am
See now Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559 at [643]ff. [read post]
2 Apr 2009, 1:40 am
H. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider… [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Cipramil (Citalopram) – UK: House of Lords upholds second-generation patent that had been invalidated at first instance for insufficiency: Generics (UK) Limited and others v H Lundbeck A/S (Managing Intellectual Property)(IPKat) US: Congressman Waxman tells GPhA meeting that Hatch-Waxman model will work for follow-on… [read post]
26 Feb 2009, 3:30 am
Generics (UK) Ltd and others v H Lundbeck A/S [2009] WLR (D) 68 “A claim for revocation on the ground of insufficiency of a patent in which claims 1 and 3 were to a product consisting of a single chemical compound and claim 6 was to a process for preparing it failed. [read post]
25 Feb 2009, 2:57 am
This morning the House of Lords, looking slightly unfamiliar without Lord Hoffmann in the line-up, gave its decision in Generics (UK) Limited and others v H Lundbeck A/S [2009] UKHL 12, dismissing Generics' appeal against the much-discussed decision of the Court of Appeal (equally unfamiliar with Lord Hofffmann in the starring role) on the application of the concept of "insufficiency" to the validity of a granted patent.In short, their Lordships -- with… [read post]
25 Feb 2009, 2:06 am
Generics (UK) Limited and others (Appellants) v H Lundbeck A/S (Respondents) [2009] UKHL 12 (25 February 2009) Source: www.parliament.uk [read post]
16 Jan 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still… [read post]
18 Apr 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Ranbaxy and AstraZeneca reach agreement in Esomeprazole patent litigation: (SmartBrief), (IPBiz), (Spicy IP), (Profitability through Simplicity), (IP Law360), (Philip Brooks), (GenericsWeb), Cadbury loses Australian battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), … [read post]
11 Apr 2008, 8:15 am
Court of Appeal (Civil Division) Odelola v Secretary of State for the Home Department [2008] EWCA Civ 308 (10 April 2008) H Lundbeck A/S v Generics (UK) Ltd & Ors [2008] EWCA Civ 311 (10 April 2008) High Court (Administrative Court) Office of Government Commerce v Information Commissioner & Anor [2008] EWHC 737 (Admin) (11 April 2008) High Court (Chancery Division) Dadourian Group International Inc & Ors v Simms & Ors [2008] EWHC 723 (Ch)… [read post]
13 Sep 2007, 1:13 am
H. [read post]
6 Sep 2007, 12:33 pm
No. 34,712 in favor of Forest Laboratories and H. [read post]
7 May 2007, 10:46 am
A recent decision from the High Court illustrates how it might be overambitious to claim patent rights over a new product when all you have done is show one way of making it.In Generics (UK) Ltd & Ors v H Lundbeck A/S, decided last Friday by Mr Justice Kitchin at the High Court, Lundbeck's patent covering Cipralex (citalopram, right) was partially revoked on application by the claimants under section 72 for being insufficiently disclosed. [read post]
